Novavax, Inc.
NASDAQ:NVAX
$1.41
-$0.01
(-0.35%)
Quote as of 1:37 PM EST on 02/10/12
|
$1.41
-$0.01
(-0.35%)
|
|
| Today's Open | $1.41 |
|---|---|
| Previous Close | $1.41 |
| Daily Range | $1.40 - $1.42 |
| 52-Week Range | $1.13 - $3.50 |
| Market Cap | $161.54M |
| P/E Ratio | -7.42 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 211,430 |
| Average Daily Volume | 1,111,716 |
| Current FY EPS | -$0.18 |
NVAX Information
| Description |
|---|
| A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
5 Reasons Not to Worry About 2012
Do the Shorts Know Something You Don't?
This Just In: Upgrades and Downgrades
Wall Street's Wrong About These Stocks
Mid-Day Update: Stock Slide Continues Amid Concern Over Economy, Employment
Three Major Indexes All Down Near 3%; Investor Concern Over Economy Grows
Alternative Vaccine Manufacturers: Novavax and Ibio
Novavax Has Over 400% Upside Potential
